FDA Balks At Trial Design For Amarin's Fish Oil Drug
Ireland-based Amarin Corp. PLC on Tuesday disclosed that the U.S. Food and Drug Administration has refused to reconsider its rejection of a clinical trial agreement aimed at dramatically widening use of...To view the full article, register now.
Already a subscriber? Click here to view full article